Single-cell RNA-sequencing (scRNA-seq) is a cutting edge innovative technology that provides unprecedented insight into the expression patterns of thousands of single cells. Individually analyzing thousands of single cells from a tissue can vastly improve the understanding of biological systems to derive vital information about diseases and immunity.
Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights.
Scientists at the Epigenetics in Human Health and Disease Laboratory, Monash University, Australia, have adopted Dolomite Bio’s Single Cell RNA-Seq System to further their research into animal models of diabetic nephropathy.
Dolomite Bio is pleased to announce the launch of a new chip for DroNc-Seq1, enabling high throughput single nucleus RNA-Seq using droplet microfluidics. The single nucleus RNA-Seq chip – based on the company’s established scRNA-Seq chip – is designed to produce smaller droplets, allowing straightforward, low cost profiling of thousands of nuclei.
A new technique – single cell RNA-sequencing – may offer answers and hope to the 200,000 mothers and partners affected by pregnancy loss in the UK every year. In partnership with Tommy’s National Centre for Miscarriage Research, scientists at the University of Warwick are currently running preliminary studies using the technique.